IBT
ASMB icon

International Biotechnology Trust’s Assembly Biosciences ASMB Stock Holding History

International Biotechnology Trust’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-425
Closed -$178K – 66
2017
Q3 		$178K Buy
+425
New +$130K 0.07% 56

Other funds holding ASMB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

International Biotechnology Trust's ASMB Position: Q4 2017 in Review

International Biotechnology Trust sold out of Assembly Biosciences (ASMB) in Q4 2017, closing a stake of 425 shares — an estimated $178K sold.

International Biotechnology Trust first reported a position in ASMB in Q3 2017 and held it in 1 quarter. The position peaked at $178K in Q3 2017. 98 funds tracked by Wall St. Rank hold ASMB as of Q4 2017.

  • International Biotechnology Trust reported no remaining Assembly Biosciences position as of Q4 2017 after selling out during the quarter.
  • International Biotechnology Trust sold 425 Assembly Biosciences shares in Q4 2017, an estimated $178K.
  • International Biotechnology Trust first reported a position in Assembly Biosciences in Q3 2017 and held it in 1 quarter.
  • International Biotechnology Trust's Assembly Biosciences position peaked at $178K in Q3 2017.
  • 98 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2017.

Based on International Biotechnology Trust's 13F filing for Q4 2017, filed 2 Mar 2018.